Novel quinoxaline-based VEGFR-2 inhibitors to halt angiogenesis
Magda M. F. Ismail, Taghreed Z. Shawer, Rabab S. Ibrahim, Rasha M. Allam, Yousry A. Ammar
Topics & Concepts
ChemistryCytotoxicityDoxorubicinSorafenibCell cultureMTT assayAngiogenesisCell cycleIC50Cell cycle checkpointQuinoxalineCell growthCancer researchCellPharmacologyIn vitroMolecular biologyBiochemistryBiologyChemotherapyGeneticsHepatocellular carcinomaOrganic chemistrySynthesis and Biological EvaluationBioactive Compounds and Antitumor AgentsSynthesis and biological activity